Table 2.
Factor | Total (N = 19) |
---|---|
Biologics prior to colectomy, n (%) | 9 (47) |
Pre-colectomy infliximab | 6 (32) |
Pre-colectomy adalimunab | 6 (32) |
Pre-colectomy certolizumab | 1 (5) |
Use of non-biologics for pouchitis, n (%) | 19 (100) |
Antibiotics (more than one course) | 19 (100) |
Mesalamine (>3 months, oral/topical) | 12 (63) |
Systemic steroids (>3 months) | 18 (95) |
Topical steroids (>3 months) | 10 (53) |
Azathioprine/6-mercaptopurine (>3 months) | 3 (16) |
Methotrexate (>3 months) | 3 (16) |
Pre-vedolizumab biologics, n (%) | 10 (53) |
Infliximab (>3 months) | 4 (21) |
Adalimumab (>3 months) | 9 (47) |